Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT04454918
Status:
COMPLETED
Last Update Posted:
2022-03-07
First Post:
2020-06-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-29
First Submit QC Date:
None
Study First Post Date:
2020-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-28
Results First Submit QC Date:
None
Results First Post Date:
2022-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-15
Last Update Post Date:
2022-03-07
Last Update Post Date Type:
ACTUAL